Research Article
Serum Amyloid Alpha in Parapneumonic Effusions
Table 4
Pleural fluid characteristics in PPE according to outcome at 6 months.
| | Favourable outcome () | Loculation/pleural thickening () | Died () |
| | Total cell count, cells/μL ×103 | 7.2 (4.2–12) | 4.37 (9.06–182.5) | 2 (1.09–13.84) | | Protein, g/dL | 4.6 (3.75–5.27) | 4.35 (2.945–4.8225) | 4.3 (2.69–4.8) | | Glucose, mg/dL* | 89 (56.45–112.75) | 5.5 (1.52–67) | 60 (13.5–83.5) | | LDH, U/L+** | 603 (340.25–1655) | 6641 (2334–9828) | 625 (463.5–9646) | | pH** | 7.34 (6.95–7.43) | 6.81 (6.21–7.06) | 7.35 (7.03–7.41) | | SAA, mg/dL | 6.7 (2.55–13.3) | 7.05 (1.27–16.87) | 1.05 (0.4–4.62) | | CRP, mg/dL | 5.2 (2.5–11.55) | 7.4 (4.07–11.72) | 4.6 (2.72–7.59) | | TNF-α, pg/mL | 25.17 (11.77–59.73) | 41.15 (6.67–57.69) | 22.95 (12.31–43.45) | | IL-1β, pg/mL* | 2.01 (0.80–11.89) | 13.33 (10.15–30.44) | 0.56 (0.162–25.54) | | IL-6, pg/mL | 341.83 (146.56–383.47) | 2.456 | 4.279 (2.6415–239.111) |
|
|
Data are presented as median (IQR).
*
and ** between favorable outcome and loculations.
|
